Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
BGLC
#8992
BioNexus Gene Lab Corp Common stock
2.265
0
USD
-2.37%
Sektor:
Grundstoffe
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
-2.37%
Monatliche Änderung
+0.89%
6 month change
+0.89%
Jahresänderung
+0.89%
Vorheriger Schlusskurs
2.320
0
Open
2.236
0
Bid
2.265
0
Ask
2.268
0
Low
2.230
0
High
2.299
9
Volumen
7
Märkte
Aktien
Grundstoffe
BGLC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.43 M
1.43 M
1.45 M
1.77 M
17.97 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.11
0.08
-0.04
-0.23
-0.15
-0.26
Return on equity %
0.16
0.1
-0.05
-0.27
-0.19
-0.31
Return on invested capital %
229.76
110.58
-16.47
-150.85
-85.49
—
Gross margin %
15.1
16.42
11.52
13.61
13.56
59.45
Operating margin %
11.18
7.9
-2.66
-26.54
-16.55
-100.09
EBITDA margin %
10.38
8.06
-3.51
-30.73
68.16
218.28
Net margin %
9.61
5.62
-3.26
-26.91
-16.81
-98.1
Liquidity ratios
Quick ratio
2.02
2.42
2.52
4.24
3.1
16.28
Current ratio
2.37
3.07
3
4.93
3.81
19.93
Inventory turnover
—
—
—
0
0.08
0.08
Asset turnover
2.01
1.36
1.19
0.97
0.91
0.99
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
-0.13
-1.14
EBIT per share
—
—
—
—
0.35
-0.41
EBITDA per share
—
—
—
—
0.36
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
—
0.09
—
Net current asset value per share
—
—
—
—
0.42
7.46
Tangible book value per share
—
—
—
—
0.47
8.88
Working capital per share
—
—
—
—
0.31
5.91
Book value per share
—
—
—
—
0.47
8.88
Nachrichten
BioNexus Gene Lab appoints commercial officer at Fidelion
BioNexus Gene Lab schließt strategische Transaktion mit Fidelion Diagnostics ab
BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics
BioNexus-Aktie gibt nach Sicherung einer 500-Millionen-Dollar-Finanzierung nach
BioNexus Gene Lab stock falls after securing $500M equity facility
BioNexus Gene Lab secures $500 million equity purchase agreement
BioNexus-Aktie steigt nach Sicherung einer Eigenkapitalfazilität über 500 Millionen US-Dollar
BioNexus Gene Lab stock climbs after securing $500 million equity facility
BioNexus-Aktie schießt nach strategischen Vereinbarungen für MRD-Tests in die Höhe
BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform
BioNexus Gene Lab stock soars after strategic MRD testing agreements
BioNexus Gene Lab files $100 million shelf registration, launches ATM program